1016 related articles for article (PubMed ID: 16966029)
1. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
[TBL] [Abstract][Full Text] [Related]
2. Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?
Bachellier P; Nakano H; Oussoultzoglou PD; Weber JC; Boudjema K; Wolf PD; Jaeck D
Am J Surg; 2001 Aug; 182(2):120-9. PubMed ID: 11574081
[TBL] [Abstract][Full Text] [Related]
3. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
Shimoda M; Mori S; Kita J; Sawada T; Kubota K
Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein resection for ductal adenocarcinoma in the head of the pancreas.
Landi F; Dopazo C; Sapisochin G; Beisani M; Blanco L; Caralt M; Balsells J; Charco R
Cir Esp; 2015 Oct; 93(8):522-9. PubMed ID: 25981612
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
[TBL] [Abstract][Full Text] [Related]
6. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
7. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.
Kaneoka Y; Yamaguchi A; Isogai M
Surgery; 2009 Apr; 145(4):417-25. PubMed ID: 19303991
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
[TBL] [Abstract][Full Text] [Related]
10. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Outcomes of Tangential
Lapshyn H; Schulte T; Petruch N; Petrova E; Honselmann K; Deichmann S; Braun R; Kulemann B; Hoeppner J; Rades D; Keck T; Wellner UF; Bausch D; Bolm L
Anticancer Res; 2021 Oct; 41(10):5123-5130. PubMed ID: 34593463
[TBL] [Abstract][Full Text] [Related]
12. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
[TBL] [Abstract][Full Text] [Related]
13. Technical risk factors for portal vein reconstruction thrombosis in pancreatic resection.
Glebova NO; Hicks CW; Piazza KM; Abularrage CJ; Cameron AM; Schulick RD; Wolfgang CL; Black JH
J Vasc Surg; 2015 Aug; 62(2):424-33. PubMed ID: 25953018
[TBL] [Abstract][Full Text] [Related]
14. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
[TBL] [Abstract][Full Text] [Related]
16. Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies.
Nakano H; Bachellier P; Weber JC; Oussoultzoglou E; Dieng M; Shimura H; Boudjema K; Wolf P; Jaeck D
Hepatogastroenterology; 2002; 49(43):258-62. PubMed ID: 11941970
[TBL] [Abstract][Full Text] [Related]
17. Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: a meta-analysis.
Yu XZ; Li J; Fu DL; Di Y; Yang F; Hao SJ; Jin C
Eur J Surg Oncol; 2014 Apr; 40(4):371-8. PubMed ID: 24560302
[TBL] [Abstract][Full Text] [Related]
18. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
[TBL] [Abstract][Full Text] [Related]
19. Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma.
Terasaki F; Fukami Y; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y
Langenbecks Arch Surg; 2019 Mar; 404(2):191-201. PubMed ID: 30631907
[TBL] [Abstract][Full Text] [Related]
20. Impact of portal vein invasion and resection length in pancreatoduodenectomy on the survival rate of pancreatic head cancer.
Kurihara C; Yoshimi F; Sasaki K; Nakao K; lijima T; Kawasaki H; Nagai H
Hepatogastroenterology; 2013 Oct; 60(127):1759-65. PubMed ID: 24634947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
